Kolkata Medical Team Pioneers AI-Powered Cervical Cancer Screening for Rural India
In a significant breakthrough for rural healthcare, a collaborative team of doctors and researchers from four institutes in Kolkata has successfully developed and validated an artificial intelligence-enabled, low-cost cervical cancer screening model specifically designed for resource-constrained settings. Their study, published recently in the Asian Pacific Journal of Cancer Prevention, demonstrates remarkable diagnostic accuracy while dramatically reducing both time and cost compared to conventional methods.
Revolutionizing Screening with Android Technology
The innovative AI model utilizes images of cervical smear samples captured through standard Android smartphones or tablets. Remarkably, the system requires a maximum of just 30 seconds to screen each sample, offering unprecedented speed in preliminary diagnostics. This represents a transformative approach to cervical cancer detection in areas where medical infrastructure is limited.
Currently, the conventional Pap smear test—which involves microscopic examination of cervical cells—remains the standard screening procedure. While the sample collection itself takes less than 30 seconds, laboratory analysis typically involves longer processing times and higher costs. In Kolkata, the average Pap smear costs approximately Rs 1,000. The new AI software has the potential to reduce this screening cost to as low as Rs 200, making preventive healthcare more accessible to underserved populations.
Study Methodology and Impressive Results
For their research, the team developed specialized AI programming software with an integrated system that automatically detects and classifies cells from microscopic Pap smear slide images. These images were captured using Android devices and analyzed through standardized validation methods. The study examined 292 smear samples collected from hospital-based laboratories at Calcutta National Medical College (CNMC) and NRS Medical College.
The findings were highly encouraging: the custom AI model successfully classified 98.1% of normal cells and 80.5% of abnormal cells in hospital in-house samples. Furthermore, researchers identified a significant correlation between AI-generated reports and biopsy results—the gold standard confirmatory test for cervical cancer.
Expert Perspectives on Rural Healthcare Impact
Pathology Associate Professor Arindam Karmakar, who was posted at CNMC during the study, emphasized the model's potential: "This AI-based cervical screening is very promising, especially in rural settings that see higher cervical cancer prevalence but lack diagnostic facilities." Priyabrata Das, Scientific Director at CliniMed Lifesciences and a member of the research team, highlighted the efficiency: "Screening using this AI tool took less than 30 seconds with a high accuracy rate."
The study, formally titled 'Evaluation of the Diagnostic Accuracy of Cervical Cell Morphologies from Android Device-Captured Cytopathological Microscopic Images through Artificial Intelligence in Mainly Rural or Resource-Constraint Areas of India', concludes that while manual screening remains time-tested, AI technology is poised to revolutionize the process by improving:
- Healthcare outreach to remote communities
- Availability of diagnostic services
- Accuracy of preliminary screenings
- Economic feasibility for widespread implementation
Snehendu Konar, Clinical Operations Lead at Auriga Research, added an important perspective: "If implemented responsibly, ethically, and with continued validation, such AI-driven tools can significantly accelerate India's progress toward reducing cervical cancer mortality."
Collaborative Research Effort
The groundbreaking study represents a collaborative effort involving multiple medical professionals and researchers. In addition to Arindam Karmakar and Priyabrata Das, the CliniMed LifeSciences team included Arindam Ray, Soumyabroto Banerjee, Swati Dasgupta, Sayan Dey, and Umar Faruk. They worked alongside Moumita Maiti from NRS Medical College and Prosenjit Saha from CNCI Kolkata, demonstrating how interdisciplinary cooperation can yield innovative solutions to pressing public health challenges.
This development marks a crucial step forward in leveraging technology to address healthcare disparities, particularly in rural India where cervical cancer remains a significant concern due to limited screening access. The AI model's combination of speed, affordability, and accuracy positions it as a potentially transformative tool in preventive oncology and women's health initiatives across resource-constrained regions.
